Pharmacy

b.well Connected Health Joins the AWS Partner Network and Is Now Available in AWS Marketplace to Accelerate Growth of Healthcare Ecosystems

Retrieved on: 
Tuesday, April 9, 2024
Connected health, FHIR, Amazon, Health, Pharmacy, APN, Senior, AWS, API, Online shopping

BALTIMORE, April 9, 2024 /PRNewswire/ -- b.well Connected Health , the company powering platform-enabled healthcare ecosystems, announced today it has joined the Amazon Web Services (AWS) Partner Network (APN).

Key Points: 
  • BALTIMORE, April 9, 2024 /PRNewswire/ -- b.well Connected Health , the company powering platform-enabled healthcare ecosystems, announced today it has joined the Amazon Web Services (AWS) Partner Network (APN).
  • b.well is a scalable, FHIR-based platform that connects healthcare ecosystems by unifying  health data, solutions, and services in one place.
  • "AWS has long been recognized as a leading cloud services provider for healthcare organizations and health tech," said Andy Harlen, Senior Vice President of Partnerships, b.well Connected Health.
  • Through AWS Marketplace, healthcare and health tech customers can more quickly and easily access b.well's platform to accelerate their digital transformation and interoperability initiatives and unlock their own ecosystems of care.

Bluesight Hospital Pharmacy Operations Report Reveals Streamlining Purchasing is Top Priority in 2024

Retrieved on: 
Tuesday, April 9, 2024
Medication, Hospital, Software, Ground substance, Pharmacy, Pharmacist, Health, Nursing

ALEXANDRIA, Va., April 9, 2024 /PRNewswire/ -- Bluesight, the leader in Medication Intelligence™ solutions, unveiled the findings of its 10th annual Hospital Pharmacy Operations Report (HPOR) .

Key Points: 
  • ALEXANDRIA, Va., April 9, 2024 /PRNewswire/ -- Bluesight, the leader in Medication Intelligence™ solutions, unveiled the findings of its 10th annual Hospital Pharmacy Operations Report (HPOR) .
  • Streamlining pharmacy operations remains a priority, driven by the need to combat drug shortages and ensure compliance.
  • Pharmacists report that inflation, an increase in shortages, and recalls are generating a new system-wide focus on optimizing purchasing operations.
  • The 10th annual Hospital Pharmacy Operations Report (HPOR) presents a detailed examination of the prevailing trends influencing hospital operations and pharmacy management across the United States in 2024.

APhA calls for strong cybersecurity measures following Change Healthcare cyberattack

Retrieved on: 
Monday, April 8, 2024
American Pharmacists Association, Trustee, Patient, Pharmacy, Education, House of Delegates, Policy, Pharmacist, Change Healthcare, House, HOD, Multimedia, Health, Nursing

WASHINGTON, April 8, 2024 /PRNewswire/ -- APhA's Board of Trustees issued the following statement calling for stronger cybersecurity measures following the Change Healthcare cyberattack.

Key Points: 
  • WASHINGTON, April 8, 2024 /PRNewswire/ -- APhA's Board of Trustees issued the following statement calling for stronger cybersecurity measures following the Change Healthcare cyberattack.
  • The Change Healthcare cyberattack made obvious the deep vulnerabilities of our nation's digital health care infrastructure, resulting in devastating patient care disruption, particularly at community and health system pharmacies across the country.
  • The APhA HOD passed the following cybersecurity policy statements.
  • APhA advocates for education providers to facilitate, and pharmacy personnel to seek out, education and training on cybersecurity laws, regulations, and best practices.

La Roche-Posay Expands Best-Selling Healing Cicaplast Collection with Cicaplast Gel B5 Skin Protectant and Cicaplast Lips Hydration Restore Lip Balm

Retrieved on: 
Monday, April 8, 2024
Pantothenic acid, SKIN, Panthenol, Face, Hyaluronic acid, Environment, Associate, Patient, Pharmacy, Dermatology, B5, Selenium, MD, Glycerol, Mineral, Skin, LIP, Sustainability, Water, Safety, LIPS, La Roche-Posay, Collection, Lip, Shea butter, Element, Cosmetics

Created for dry to very dry and sensitive lips, CICAPLAST LIPS HYDRATION RESTORE LIP BALM soothes and softens with a non-greasy texture.

Key Points: 
  • Created for dry to very dry and sensitive lips, CICAPLAST LIPS HYDRATION RESTORE LIP BALM soothes and softens with a non-greasy texture.
  • Formulated with Vitamin B5 (Panthenol), sustainably sourced Shea Butter and La Roche-Posay Thermal Spring Water, CICAPLAST LIPS HYDRATION RESTORE LIP BALM restores the skin's hydrolipidic film and helps soothe skin.
  • Now, with the launch of CICAPLAST LIPS HYDRATION RESTORE LIP BALM and CICAPLAST GEL B5 SKIN PROTECTANT, La Roche-Posay is proud to continue to expand its best-selling and healing CICAPLAST collection.
  • CICAPLAST LIPS HYDRATION RESTORE LIP BALM and CICAPLAST GEL B5 SKIN PROTECTANT are:

Mercy Takes Steps to Build New Medical Campus in Wentzville

Retrieved on: 
Friday, April 5, 2024
Lincoln, United States Census Bureau, Letter, Interstate 70, Sister, Physician, Mackin, Patient, Pharmacy, Intuition, Travel, Hospital, Mercy Hospital St. Louis, Mercy Hospital, National Research Corporation, Medicaid, Heart, Multimedia, Interstate 64, Update, Nursing, Interstate Highway System, Feedback

Mercy intends to expand its model of affordable health care to the tri-county area in the years to come.

Key Points: 
  • Mercy intends to expand its model of affordable health care to the tri-county area in the years to come.
  • Our data shows us many Mercy patients travel, sometimes more than an hour, from Lincoln and Warren counties into St. Louis County.
  • This investment will create jobs and significantly enhance health care services in this area, positioning Wentzville as a regional destination for health care," said Wentzville Mayor Nick Guccione.
  • "We welcome Mercy to Wentzville, confident that it will help meet our growing health care needs and contribute to our area's vitality."

Workers at the Delta by Marriott in Thunder Bay Vote to Join UFCW Local 175

Retrieved on: 
Thursday, March 21, 2024
Ontario Labour Relations Board, Union, Motivation, OLRB, Local, UFCW, Receptionist, Pharmacy, Workplace, Foodservice, Food, Pension fund

MISSISSAUGA, Ontario, March 21, 2024 (GLOBE NEWSWIRE) -- The 84 employees working at the Delta by Marriott hotel in Thunder Bay are celebrating today after their vote to join Local 175 of the United Food & Commercial Workers (UFCW) was a success.

Key Points: 
  • MISSISSAUGA, Ontario, March 21, 2024 (GLOBE NEWSWIRE) -- The 84 employees working at the Delta by Marriott hotel in Thunder Bay are celebrating today after their vote to join Local 175 of the United Food & Commercial Workers (UFCW) was a success.
  • “Like many people out there, these workers were looking for a way to build a better life,” said Kelly Tosato, President of UFCW Local 175.
  • That vote took place online over a 24-hour period, closing at noon on March 21, 2024, to determine whether UFCW Local 175 would become the certified bargaining representative for the workers.
  • The OLRB released the results shortly after the vote closed, assuring these workers are now Union members with UFCW Local 175.

BrightSpring Health Services’ Specialty Pharmacy Onco360® Celebrates Excellent Patient Care and Preferred Pharmacy Status

Retrieved on: 
Thursday, March 14, 2024
Diagnosis, Health care, Disease, Selinexor, Partnership, Patient, Pharmacy, Multiple myeloma, Pharmacist, Cancer, B cell, NPS, Insurance, Patient satisfaction, DLBCL, Health, Hospital

“At BrightSpring Health Services, we are proud of our leading service lines like Onco360® as we continue to innovate in the health care industry and provide patients with life-improving and life-sustaining treatments,” said BrightSpring President and CEO Jon Rousseau.

Key Points: 
  • “At BrightSpring Health Services, we are proud of our leading service lines like Onco360® as we continue to innovate in the health care industry and provide patients with life-improving and life-sustaining treatments,” said BrightSpring President and CEO Jon Rousseau.
  • “It is an honor for Onco360® to be selected as the preferred pharmacy for XPOVIO® (selinexor) and shows the Company’s dedication to innovation, quality patient care and improving health outcomes.
  • Onco360® and its dedicated employees do a fantastic job of keeping BrightSpring’s important mission at the core of everything they do.”
    As another demonstration of BrightSpring and Onco360®’s commitment to patient care, this year, Onco360® celebrates excellent service and care that resulted in unmatched patient satisfaction scores.
  • “It’s incredibly important to us to provide patient care that prioritizes expertise, reliability, consistency, and overall satisfaction,” said Benito Fernandez, Chief Commercial Officer at Onco360®.

Onco360® Celebrates Excellent Patient Care, Reflected by Impressive Net Promoter Score

Retrieved on: 
Thursday, March 14, 2024
NPS, Insurance, Caregiver, Patient, Patient satisfaction, Health, Cancer, Pharmacy

LOUISVILLE, Ky., March 14, 2024 (GLOBE NEWSWIRE) -- This year, Onco360®, the nation’s leading independent specialty oncology pharmacy, celebrates excellent service and care that resulted in unmatched patient satisfaction scores.

Key Points: 
  • LOUISVILLE, Ky., March 14, 2024 (GLOBE NEWSWIRE) -- This year, Onco360®, the nation’s leading independent specialty oncology pharmacy, celebrates excellent service and care that resulted in unmatched patient satisfaction scores.
  • Onco360®’s net promoter score (NPS) saw an 11-point increase, reaching an impressive 94, while the rest of the industry averaged 74 points.
  • “At Onco360®, we are committed to improving the lives of patients battling cancer and our recent net promoter score proves that our personalized services and specialized teams are making a positive difference in the lives of those we serve,” said Benito Fernandez, Chief Commercial Officer.
  • In fact, 94% of Onco360® patients reported they would be upset if forced to use a different specialty pharmacy.

Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Thursday, March 14, 2024
Research, Certification, Quarter, Prevalence, Teva Pharmaceuticals, Gastrointestinal disease, Partnership, ACG, Metoclopramide, Patient, Pharmacy, Gastroparesis, Health care, Holocene, Prescription, Orange Book, Marketing, Gastroenterology, Woman, DDW, PBM, Hospital, Pharmaceutical industry

SOLANA BEACH, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today announced its financial results for the fourth quarter and full year ended December 31, 2023, and recent corporate developments.

Key Points: 
  • Our commercial team’s dedicated efforts yielded a 107% increase in year-over-year revenue,” stated Dave Gonyer, R.Ph., CEO of Evoke Pharma.
  • Research and development expenses totaled approximately $23,000 for the fourth quarter of 2023 compared with $27,000 for the fourth quarter of 2022.
  • For the fourth quarter of 2023 selling, general and administrative (SG&A) expenses were approximately $3.5 million compared with $2.3 million for the fourth quarter of 2022.
  • Total operating expenses for the fourth quarter of 2023 were approximately $3.6 million compared with $2.3 million for the same period of 2022.

Cost control rationale for pharmacare does not stand up to scrutiny: Canadian Health Policy Institute

Retrieved on: 
Thursday, March 14, 2024
Annual report, Physician, Pan-Canadian Pharmaceutical Alliance, Patient, Pharmacy, Hospital, Public Health Agency, Policy, Overalls, PMPRB, Agency, Parity, CIHI, Pharmacare, NDP, Government

TORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- The latest edition of an annual study from the Canadian Health Policy Institute concludes that the cost control rationale for national pharmacare is not supported by the facts.

Key Points: 
  • TORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- The latest edition of an annual study from the Canadian Health Policy Institute concludes that the cost control rationale for national pharmacare is not supported by the facts.
  • It is a symbolic step toward a national pharmacare program that will replace existing public and private drug plans.
  • Pharmacare advocates are betting a single payer can demand deeper discounts without jeopardizing the availability of new medicines in Canada.
  • Excessive cost controls for patented medicines are counterproductive.”
    “It appears unlikely that the current government will rethink its pharmacare policy.